AgeX Therapeutics, Inc.
(NYSE Amex Equities : AGE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.58%149.060.7%$734.24m
BMYBristol-Myers Squibb Co. -0.08%66.731.0%$726.64m
PFEPfizer Inc. -0.25%40.510.9%$611.72m
MRKMerck & Co., Inc. -0.22%90.980.7%$577.92m
ABBVAbbVie, Inc. -1.40%88.012.3%$545.73m
LLYEli Lilly & Co. -1.29%139.611.1%$400.65m
APLSApellis Pharmaceuticals, Inc. 0.30%40.500.0%$107.43m
NVSNovartis AG 0.88%95.940.2%$101.60m
AZNAstraZeneca Plc 1.62%51.331.2%$98.49m
GSKGlaxoSmithKline Plc 1.55%47.890.2%$84.36m
KRTXKaruna Therapeutics, Inc. 9.17%104.520.0%$68.78m
SNYSanofi 0.10%51.240.2%$68.67m
NVONovo Nordisk A/S -0.02%61.300.1%$64.41m
RETAReata Pharmaceuticals, Inc. -2.24%211.433.5%$64.03m
TPTXTurning Point Therapeutics, Inc. 2.72%59.950.0%$40.48m

Company Profile

AgeX Therapeutics, Inc. operates as a biotechnology company. It focuses on the development and commercialization of novel therapeutics targeting human aging. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.